Chapter 899: The dumb ate coptis

Throughout the summer of 1984, Tan Zhenhua spent the whole busy schedule. It was not until the end of August when the new semester was about to begin, when the dust finally settled.
The acquisition of Amgen Pharmaceuticals went smoothly. Due to Sargent’s mediation, the original board of directors agreed to the original Amgen’s price of 35 million U.S. dollars, Sargent invested an additional 5 million U.S. dollars, and Tan Zhenhua invested 10 million U.S. dollars. , Tan Zhenguo’s "invention" was valued at 10 million US dollars.
Uh, by the way, there is also an investor who has been killed halfway-the newly established "hyperbolic" investment company has also mixed this round of venture capital. The CEO of Vivian made her first life. In a venture capital case, US$3 million was invested in "Amgen Pharmaceuticals" and obtained a 4.76% stake in the company.
This also brings the total valuation of Amgen Pharmaceuticals to $63 million.
In addition, at the request of Tan Zhenguo, his equity included the payment of US$500,000 each to the remaining six brothers in the same dormitory of Aurora University. According to him, these buddies are in the "Nafei" has made great contributions to the "development" of this new drug, especially the youngest, and willing to be the first human experimenter...
Of course, Tan Zhenhua has no opinion on this. In fact, he still intends to bring Tan Zhenguo's six classmates to the United States to join the Amgen pharmaceutical company, because his and Tan Zhenguo’s equity is added together, even if the "hyperbolic" is added. The share of the company accounted for 36.5% of the total shares. Taking into account the general operating rules of companies such as the United States, it is inevitable that there will be several rounds of venture capital financing in the future, and they must be listed in the future. The proportion of shares in the hands of
people
will further decline. Therefore, deploying personnel in the company in advance is actually a necessary means to maintain a certain right to speak in the company.
Of course, the happiest person is Tan Zhenguo. As soon as he arrived in the United States, he had 10 million-oh, to be precise, it should be a net worth of 7 million US dollars. Although this money is only paper wealth, it is enough for him. Excited.
At this time, he finally understood what Tan Zhenhua meant when he said that "a lifetime's rice bowl is pointing to it".
I also understood why Tan Zhenhua asked him to temporarily lock it in a drawer when this baby was first found out, and he also solemnly asked all the brothers who participated in this matter to keep the secret strictly.
After all, it’s worth 10 million, or US dollars. Can it be kept secret?
Of course, in a few years, when this medicine is on the market, Tan Zhenguo will understand how much this paper formula is worth.
The wonders of the world don't stop there.
In the 1970s and 1980s, thanks to the encouragement of policies, a large number of small and medium-sized pharmaceutical companies were born in the United States. Among these companies, several future industry giants were also bred.
For example, the "Genentech" company that Tan Zhenhua used as a spare tire.
In 2008, when Swiss "Roche Pharmaceuticals" acquired this "Genentech", it spent a full 46.8 billion US dollars!
And what about Amgen?
In another time and space, Amgen Pharmaceuticals ranked 7th on the list of the world's most valuable pharmaceutical companies in 2018, with annual sales revenue of 23.7 billion U.S. dollars and a market value of 124 billion!
Please pay special attention to the fact that this is the result achieved when it did not obtain the gold mine of "Sildenafil Citrate". What about the "Pfizer Pharmaceuticals" that developed this gold mine? It ranks second in the world, with sales revenue of 53.6 billion in 2018 and a market value of $253.6 billion!
Tan Zhenhua did not carry the "Du Niang" system with him. He did not play biomedicine in his previous life. Of course he didn't know this, but one thing he can be sure of is that Pfizer does not have the blessing of "Sidenafil Citrate". , It will never be possible to regain the glory of his previous life, because Amgen Pharmaceuticals will take its place, and he himself will be given the biggest piece of cake.
The matter of Amgen Pharmaceuticals has come to an end. The next thing to worry about is of course the big construction site-although the three new headquarters buildings under planning have not yet started, under the pressure of Vivian’s due diligence supervisor, two old buildings The decoration of the building has finally been completed. Cisco, SGI, and MIPS have also moved into one of them. Although it is still a bit crowded, it is much better than their original office environment.
And on the first day that these three companies moved into the new office, Vivienne announced another piece of news that shocked everyone - Hyperbola would invest in these three companies, including the amount of investment in SGI It is $2 million, while Cisco and MIPS are both $1 million.
So Vivienne, are you declaring your identity as the future boss lady in another way?
Everyone looked at Tan Zhenhua with a meaningful look, and Dr. Hennessy came up and patted him on the shoulder-well, they must all think that this was secretly instructed by Tan Zhenhua, and only he himself ate Huanglian like a dumb.
What is this girl messing about? Asking you to be a venture capitalist is not asking you to follow me! Hyperbolic, right? I am the biggest investor. I want to open a board of directors to criticize you!
All the directors will be there soon, and they are all gathered in the meeting room on the top floor of another building. This building was originally reserved for the "Matrix" laboratory, but Vivienne It bluntly occupies the top floor as a "hyperbolic" office space.
But when Tan Zhenhua walked into the conference room triumphantly, intending to show off the prestige of his main investor, he realized that he had made a huge mistake.
To tell the truth, at this moment, he can't wait to slap his face.
You said I'm good, what kind of board do you have?
Look who is sitting in this room?
Senior brother Li Yanan was whispering to Kaidi, whose stomach was already the size of a watermelon, and his face was full of warmth; Li Zhekai inserted a few witty words from time to time, which attracted Kaidi's smirk while covering his mouth and Li Yanan's eyes.
What a cozy scene of a family gathering...
There were two middle-aged people in the room with serious faces in formal dresses, but these two seemed even more unkind, and Tan Zhenhua looked at their faces with a guilty whisper—because of the appearance of these two faces. , Too similar to Vivian, right?
There is no need for him to guess, Vivienne has already introduced him in a serious manner: "This is Mr. Lu Yongjian, currently serving as a department manager in the investment banking department of Bank of America, and a special financial consultant for our "hyperbolic" investment company; It is Mr. Lu Yongming, currently serving as the company’s chief financial officer."
Yes, not only the directors are here today, but even all the employees of the company are not down.
Tan Zhenhua hurriedly said: "Uncle, San uncle, hello."
Lu Yongming shook hands with him, grinned at him, and then winked again.
It seems that the third uncle is still very good at dealing with.
But the other one is not so polite.
Lu Yongjian looked at him up and down for a long time before he hummed from his nostrils as a response, and then said coldly: "Vivian said you are going to have a meeting, then, let's go."
After that, he turned around and went back to his seat to sit down, putting on a posture of sitting in a dreadful manner.
Cover your face.jpg.
How can I open this board of directors?